Topic: Cardiology

Dive Brief: FDA awarded premarket approval to Terumo’s MicroVention subsidiary for a flow diversion system […]

Masimo has won FDA clearance for its RD SET sensors, that feature the company’s signature […]

Vancouver, Canada, Jan. 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the […]

iRhythm Technologies (NSDQ:IRTC) shares are slightly up today on third-quarter results that came up short of […]

The FDA has yet another private listing of device-related deaths, this one for transcatheter aortic […]

iRhythm Technologies (NSDQ:IRTC) shares are slightly up today on third-quarter results that came up short of […]

Mayo Clinic researchers this spring plan to try out Corindus’ telestenting technology — which Mayo […]

Dive Brief: Digital health company Eko said Wednesday it received FDA’s breakthrough device designation for […]

Adagio Medical announced that it enrolled the first patient in its iCLAS investigational device exemption clinical […]

iRhythm Technologies (NSDQ:IRTC) announced that it is participating in a new Bristol-Myers Squibb–Pfizer (NYSE:PFE) Alliance study for reducing […]

ControlRad announced today that it made several additions to its leadership team, naming a new chief […]

Heart pump company Abiomed (NSDQ:ABMD) has begun a clinical trial to determine whether pumping blood from the […]

Robocath announced today that it successfully completed the first robotic coronary angioplasties on the continent of […]

Chronic obstructive pulmonary disease (COPD) has few treatment options, with patients frequently experiencing shortness of […]

InspireMD (NYSE:NSPR) announced today that president & CEO James Barry is stepping down, effective Dec. 31, […]

NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a […]

Recent results of a collaborative study between Eko and the Mayo Clinic demonstrating the use of […]

PARIS and BOSTON, Dec. 9, 2019 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today […]

Dive Brief: Abbott is warning doctors of the potential for harm to patients from two […]

Abbott (NYSE:ABT) has issued a field safety notice for its HeartMate 3 Left Ventricular Assist System […]

Edwards Lifesciences changed the way heart valve disease is treated in 2019. It was not […]

MILAN, Dec. 5, 2019 /PRNewswire/ — InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems […]

Dive Brief: Edwards Lifesciences intends to match the high it set this year for R&D spending […]

At the RSNA conference in Chicago, Samsung unveiled a new high-end ultrasound, the RS85 Prestige. […]

Digital healthcare company iRhythm has launched its Zio service in the UK to support the […]

Dive Brief: Edwards Lifesciences issued fiscal guidance for 2020 Thursday morning, targeting sales in the […]

A long-term followup study on Boston Scientific’s (NYSE:BSX) Watchman heart implant shows low risk of hemorrhagic stroke […]

TransMedics (NSDQ:TMDX) announced today that the doctors at two hospitals performed the first U.S. heart transplants […]

Dive Brief: Two long-term studies of FDA-mandated registries have linked Boston Scientific’s left atrial appendage […]

  TransMedics (NSDQ:TMDX) announced today that the doctors at two hospitals performed the first U.S. […]

The survival rate of right-heart failure patients treated with the Abiomed (NSDQ:ABMD) Impella RP heart pump remained […]

Investors are getting behind Impulse Dynamics’s implantable device that helps treat heart failure. The Mount […]

VivaLNK, a Silicon Valley company, won the European CE Mark for its VivaLNK multi-vital medical […]

Royal Philips (NYSE:PHG) announced today that the millionth procedure performed with its Azurion image-guided therapy platform […]

FDA Wants Medtech to Cut Back on EtO Use FDA is encouraging manufacturers to reduce […]

Attune Medical is hoping to get a label expansion for its device to reduce thermal […]

Dive Brief: A retrospective cohort study has linked pulmonary hypertension to increased mortality and readmission […]

Dive Brief: FDA granted breakthrough device designation to BioVentrix’s heart failure technology, the company said […]

Dive Brief: LivaNova will end its transcatheter mitral valve replacement program as part of a […]